Indications and uses
prevents and treats nausea, vomiting or dizziness due to motion sickness.
prevents and treats nausea, vomiting or dizziness due to motion sickness.
Dosage should be taken one hour before travel starts Adults and children 12 years and older: Chew 1-2 tablets once daily, or as directed by a doctor Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor
Phenylketonurics: Contains Phenylalanine 0.0025 mg per tablet Store at room temperature in a dry place Keep lid tightly closed
Meclizine HCl, USP 25 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness due to motion sickness.
Do not use in children under 12 years of age unless directed by a doctor
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact the poison control center immediately
aspartame, colloidal silicon dioxide, croscarmellose sodium, dextrose, lake of FD & C Red 40, magnesium stearate, maltodextrin, microcrystalline cellulose, raspberry flavor, sodium sulfate anhydrous, sucrose, tribasic calcium phosphate
Call 1-844-200-6566 Monday to Friday 9 AM to 5 PM EST
TAMPER EVIDENT: DO NOT USE IF FOIL SEAL UNDER CAP, PRINTED WITH “SEALED for YOUR PROTECTION” IS BROKEN OR MISSING
Distributed by:
Drug Ocean LLC,
1 Bridge Plaza, North Central Road
6th Floor, Suite 675
Fort Lee, NJ 07024
Manufactured by:
Unique Pharmaceutical Laboratories
(A Div. of J. B. Chemicals & Pharmaceuticals Ltd.)
Mumbai 400 030, India
ORG 12/23
NDC 70985-010-01
Meclizine Hydrochloride Chewable Tablets 25mg
(ANTIEMETIC)
Travel Sickness
100 tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 95250459-30e4-45c1-b08a-993044f49109 | Product name | 2 | 20250805 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| 9badc7be-250a-44ab-aa36-926af3f02679 | Product name | 1 | 20210527 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 26acd337-b838-40ac-bcbc-05c3b81c8712 | Product name | 1 | 20170323 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70985-010-01 | 2026-01-29 | C162847 | 48780-1 | 49896155-a8dc-586f-e063-e6dba90add90 | MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70985-010-01 | Meclizine HCl | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70985-010 | 70985-010-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUCROSE | C151H8M554 | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| TRIBASIC CALCIUM PHOSPHATE | 91D9GV0Z28 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| RASPBERRY | 4N14V5R27W | IACT |
| SODIUM SULFATE ANHYDROUS | 36KCS0R750 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0d305bb7-f894-4b45-e063-6294a90ad8ed | eebd2801-62a7-471d-8e39-ac9677864aa5 | 2023-12-23 | Warnings | 0d305bb7-f894-4b45-e063-6294a90ad8ed eebd2801-62a7-471d-8e39-ac9677864aa5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.